Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist
October 17, 2024
CEO Joseph Johnson discusses the creation of digital tools that allow transparency within the boating market, making waves by setting standards for industry sales.